Women like me: Reflections on health and hormones from women treated for breast cancer

被引:5
作者
Bond, B
Hirota, L
Fortin, J
Col, N
机构
[1] Tufts Univ New England Med Ctr, Dept Social Work Serv, Boston, MA 02111 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Brigham & Womens Hosp, Decis Syst Grp, Dept Radiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
breast cancer; hormone replacement therapy; decision making; menopausal symptoms; risk perception;
D O I
10.1300/J077v20n03_03
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Hormone replacement therapy (HRT) traditionally has been withheld from women with breast cancer to minimize their risk of recurrence. However, the benefits of HRT include relief from menopausal symptoms and protection against osteoporosis and possibly heart disease. Focus groups were conducted among women diagnosed with breast cancer to explore how the women approached health decisions, especially regarding HRT, and to identify factors that influenced their decision-making process. Factors identified included relief of symptoms, fear of cancer, side effects of treatment, attitudes toward risk, perception of risk and mastery, and physicians' recommendations. The article discusses these factors and provides suggestions, such as the following, to care providers who counsel women concerning menopause and HRT: Help patients understand areas in which the evidence is solid, address their possibly unrealistic expectations, and help them articulate their feelings and fears.
引用
收藏
页码:39 / 56
页数:18
相关论文
共 21 条
[1]   FOCUS GROUP INTERVIEW - AN UNDERUTILIZED RESEARCH TECHNIQUE FOR IMPROVING THEORY AND PRACTICE IN HEALTH-EDUCATION [J].
BASCH, CE .
HEALTH EDUCATION QUARTERLY, 1987, 14 (04) :411-448
[2]   Hormone replacement therapy (HRT) after breast cancer treatment - Results from an observational study. [J].
Beckmann, MW ;
Mohrmann, T ;
Kuschel, B ;
Dadze, A ;
Mohrmann, S ;
Dall, P ;
Nitz, U ;
Schnurch, HG ;
Bender, HC .
GEBURTSHILFE UND FRAUENHEILKUNDE, 1998, 58 (04) :193-196
[3]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[4]  
Clarke M, 1998, LANCET, V351, P1451
[5]  
Col NF, 2000, J GEN INTERN MED, V15, P59
[6]   Patient-specific decisions about hormone replacement therapy in postmenopausal women [J].
Col, NF ;
Eckman, MH ;
Karas, RH ;
Pauker, SG ;
Goldberg, RJ ;
Ross, EM ;
Orr, RK ;
Wong, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (14) :1140-1147
[7]   Hormone replacement therapy after breast cancer: A systematic review and quantitative assessment of risk [J].
Col, NF ;
Hirota, LK ;
Orr, RK ;
Erban, JK ;
Wong, JB ;
Lau, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2357-2363
[8]   Patient-identified needs for hormone replacement therapy counseling: A qualitative study [J].
Connelly, MT ;
Ferrari, N ;
Hagen, N ;
Inui, TS .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (04) :265-268
[9]   PREVALENCE OF MENOPAUSAL SYMPTOMS AMONG WOMEN WITH A HISTORY OF BREAST-CANCER AND ATTITUDES TOWARD ESTROGEN REPLACEMENT THERAPY [J].
COUZI, RJ ;
HELZLSOUER, KJ ;
FETTING, JH .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2737-2744
[10]   Hormone replacement therapy in breast cancer survivors: A cohort study [J].
DiSaia, PJ ;
Grosen, EA ;
Kurosaki, T ;
Gildea, M ;
Cowan, B ;
AntonCulver, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (05) :1494-1498